ECSP11011497A - Radiotrazadores pet para la imagimática del metabolismo y conservación de ácidos grasos - Google Patents
Radiotrazadores pet para la imagimática del metabolismo y conservación de ácidos grasosInfo
- Publication number
- ECSP11011497A ECSP11011497A ECSP11011497A ECSP11011497A EC SP11011497 A ECSP11011497 A EC SP11011497A EC SP11011497 A ECSP11011497 A EC SP11011497A EC SP11011497 A ECSP11011497 A EC SP11011497A
- Authority
- EC
- Ecuador
- Prior art keywords
- fatty acids
- metabolism
- radiotrazers
- imagimatics
- conservation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/132—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Se describen moléculas del análogo de ácido graso (FAA) que comprenden radionúclidos, de emisión de positrones, sales de éstos, y FAA-triglicéridos. Se describen, además, los métodos de síntesis, y métodos de distribución de imágenes y metabolismo de los ácidos grasos y triglicéridos de ácidos grasos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17506509P | 2009-05-04 | 2009-05-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP11011497A true ECSP11011497A (es) | 2012-03-30 |
Family
ID=43050827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP11011497 ECSP11011497A (es) | 2009-05-04 | 2011-12-01 | Radiotrazadores pet para la imagimática del metabolismo y conservación de ácidos grasos |
Country Status (19)
Country | Link |
---|---|
US (1) | US20120100073A1 (es) |
EP (1) | EP2427218A4 (es) |
JP (1) | JP2012526129A (es) |
KR (1) | KR20120060943A (es) |
CN (1) | CN102421454A (es) |
AU (1) | AU2010246010A1 (es) |
BR (1) | BRPI1014538A2 (es) |
CA (1) | CA2760334A1 (es) |
CL (1) | CL2011002753A1 (es) |
CO (1) | CO6460756A2 (es) |
CR (1) | CR20110637A (es) |
EA (1) | EA201171355A1 (es) |
EC (1) | ECSP11011497A (es) |
IL (1) | IL216124A0 (es) |
MX (1) | MX2011011743A (es) |
NO (1) | NO20111663A1 (es) |
SG (1) | SG175430A1 (es) |
WO (1) | WO2010129572A2 (es) |
ZA (1) | ZA201108053B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201021369D0 (en) * | 2010-12-16 | 2011-01-26 | Ge Healthcare Ltd | Radioiodinated fatty acids |
WO2014030650A1 (ja) | 2012-08-20 | 2014-02-27 | 大塚製薬株式会社 | 糖代謝能の測定方法及びそれに使用する組成物 |
KR20150132301A (ko) * | 2013-03-15 | 2015-11-25 | 오츠카 세이야쿠 가부시키가이샤 | 지방산 연소에 의한 인슐린 저항성의 측정 방법, 및 그에 사용하는 조성물 |
US20160185735A1 (en) * | 2013-08-12 | 2016-06-30 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Fatty acid analogs and their use |
US10457642B2 (en) | 2015-05-04 | 2019-10-29 | The Trustees Of The University Of Pennsylvania | 211-astatine containing radiotherapeutics for the treatment of cancer |
EP3825302A4 (en) | 2018-07-20 | 2022-05-04 | Astellas Pharma Inc. | FATTY ACID DERIVATIVE LABELED WITH POSITRON-emitting radionuclide |
WO2021145403A1 (ja) * | 2020-01-17 | 2021-07-22 | アステラス製薬株式会社 | 陽電子放出核種で標識された脂肪酸誘導体 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2846491A (en) * | 1955-12-13 | 1958-08-05 | Air Reduction | Reactions of sodium acetylide with alkyl halides |
EP0136879A3 (en) * | 1983-09-30 | 1987-01-07 | Yamanouchi Pharmaceutical Co., Ltd. | Fatty acid derivatives and processes of producing them |
EP0327523B1 (en) * | 1988-02-03 | 1992-06-17 | Washington University | Novel fatty acid analog enzyme substrates |
ES2088480T3 (es) * | 1990-10-12 | 1996-08-16 | Univ Washington | Sustratos de enzimas analogos de acidos grasos sustituidos con azido. |
US5401493A (en) * | 1993-03-26 | 1995-03-28 | Molecular Biosystems, Inc. | Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same |
US5747537A (en) * | 1995-09-05 | 1998-05-05 | Washington University | Method of inhibiting parasitic activity |
ATE353019T1 (de) * | 1995-12-01 | 2007-02-15 | Molecular Insight Pharm Inc | Stereoisomere von fettsäureanalogen zur diagnostischen bildgebung |
JP4415216B2 (ja) * | 2002-02-01 | 2010-02-17 | 大日本住友製薬株式会社 | 2−フランカルボン酸ヒドラジド化合物及びそれを含有する医薬組成物 |
WO2004093650A2 (en) * | 2003-04-17 | 2004-11-04 | The General Hospital Corporation | Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid |
CN1886362B (zh) * | 2003-07-24 | 2010-10-13 | 皇后医学中心 | 烷基化剂的制备和用途 |
JP4455413B2 (ja) * | 2004-06-11 | 2010-04-21 | キヤノン株式会社 | ビニル基、エステル基、カルボキシル基並びにスルホン酸基を有するポリヒドロキシアルカン酸並びにその製造方法 |
-
2010
- 2010-05-04 US US13/319,001 patent/US20120100073A1/en not_active Abandoned
- 2010-05-04 JP JP2012509908A patent/JP2012526129A/ja active Pending
- 2010-05-04 SG SG2011080314A patent/SG175430A1/en unknown
- 2010-05-04 CA CA2760334A patent/CA2760334A1/en not_active Abandoned
- 2010-05-04 WO PCT/US2010/033579 patent/WO2010129572A2/en active Application Filing
- 2010-05-04 MX MX2011011743A patent/MX2011011743A/es unknown
- 2010-05-04 AU AU2010246010A patent/AU2010246010A1/en not_active Abandoned
- 2010-05-04 EA EA201171355A patent/EA201171355A1/ru unknown
- 2010-05-04 EP EP10772712.5A patent/EP2427218A4/en not_active Withdrawn
- 2010-05-04 BR BRPI1014538A patent/BRPI1014538A2/pt not_active IP Right Cessation
- 2010-05-04 CN CN201080020060XA patent/CN102421454A/zh active Pending
- 2010-05-04 KR KR1020117028765A patent/KR20120060943A/ko not_active Application Discontinuation
-
2011
- 2011-11-02 ZA ZA2011/08053A patent/ZA201108053B/en unknown
- 2011-11-03 IL IL216124A patent/IL216124A0/en unknown
- 2011-11-04 CL CL2011002753A patent/CL2011002753A1/es unknown
- 2011-11-11 CO CO11154118A patent/CO6460756A2/es not_active Application Discontinuation
- 2011-11-29 CR CR20110637A patent/CR20110637A/es unknown
- 2011-12-01 EC ECSP11011497 patent/ECSP11011497A/es unknown
- 2011-12-02 NO NO20111663A patent/NO20111663A1/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CL2011002753A1 (es) | 2012-07-13 |
EA201171355A1 (ru) | 2012-05-30 |
US20120100073A1 (en) | 2012-04-26 |
WO2010129572A3 (en) | 2010-12-29 |
CR20110637A (es) | 2012-02-09 |
CA2760334A1 (en) | 2010-11-11 |
KR20120060943A (ko) | 2012-06-12 |
CO6460756A2 (es) | 2012-06-15 |
ZA201108053B (en) | 2012-07-25 |
WO2010129572A2 (en) | 2010-11-11 |
AU2010246010A1 (en) | 2011-11-17 |
IL216124A0 (en) | 2012-01-31 |
MX2011011743A (es) | 2011-11-29 |
NO20111663A1 (no) | 2011-12-02 |
EP2427218A2 (en) | 2012-03-14 |
BRPI1014538A2 (pt) | 2016-04-05 |
JP2012526129A (ja) | 2012-10-25 |
CN102421454A (zh) | 2012-04-18 |
EP2427218A4 (en) | 2014-06-18 |
SG175430A1 (en) | 2011-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP11011497A (es) | Radiotrazadores pet para la imagimática del metabolismo y conservación de ácidos grasos | |
CL2020002805A1 (es) | Método para identificar un modulador de un sistema biológico; método para identificar un modulador de un proceso de enfermedad (divisional 201302526) | |
ES2535839T3 (es) | Composición de un gel que comprende pectina ligeramente metoxilada | |
CU20190058A7 (es) | Composiciones de aminoácidos relacionadas con mejoras de la función hepática | |
AR085507A1 (es) | Animales modificados geneticamente y metodos para su obtencion | |
UY31858A (es) | 3-metil-7-(2-butin-1-il)-8-(3-(r)-amino-piperidin-1-il)-xantinas y sus sales farmacéuticamente aceptables como inhibidores de dpp-4 para aplicaciones terapéuticas | |
ECSP13012715A (es) | Método para producir preparados farmacéuticos con contenido de ibp | |
EA201590026A1 (ru) | Выработка длинноцепочечных полиненасыщенных жирных кислот в растительных клетках | |
ES2643848T3 (es) | Método para cuantificar dosis UV desinfectantes usando indicadores | |
UY32037A (es) | Daa-piridina | |
NI201100205A (es) | Sales de disacarina, ácido difumárico, acido di - 1 - hidroxi - 2 - naftoico y ácido monobenzoico del 2 - ( 4 - (( 2 - amino - 4 - metil - 6 - ( pentilamino ) pirimidin - 5 - il ) metil ) fenil ) acetato de 4 - ( dimetilamino ) butilo | |
BR112012018131A2 (pt) | aparelho, servidor, método e sistema de agrupamento de produto, e, meio de gravação | |
CL2013001604A1 (es) | Compuestos derivados de pirimidinona sustituida; composicion farmaceutica que los comprende; su uso para tratar la enfermedad de alzheimer y la aterosclerosis. | |
BR112015030268A2 (pt) | composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição | |
CU20120162A7 (es) | Colorantes de perileno enlazados a polímero y composiciones que los contienen | |
ES2596248T3 (es) | N-Carbamoilputrescina para mejorar la síntesis de proteínas musculares | |
ES2508165T3 (es) | Lactoferrina y sustancia blanca | |
BR112015030135A2 (pt) | ésteres de ácidos oligo-hidróxi carboxílicos e seu uso | |
BR112012016054A2 (pt) | Composições nutricionais compreendendo flocos de fruta incluindo ácido docosa-hexaenoico | |
UY35856A (es) | Producción de acidos grasos poliinsaturados de cadena larga omega 3 en los cultivos de oleaginosas por una sintasa pufa traustoquitridio. | |
AR081465A1 (es) | Uso de marcadores especificos de gen nervadura-3 marron (“brown 3-midrib”) en maiz para introgresion de rasgos | |
CL2016002362A1 (es) | Composiciones semioquímicas para reducir conflictos sociales con gatos. | |
AR092423A1 (es) | Metodo de diagnostico y tratamiento del cancer dirigido a las moleculas expresadas en celulas madre cancerosas | |
BR112014008527A2 (pt) | núcleo absorvente | |
CL2011000621A1 (es) | Agente que contiene por lo menos un acido acilciclohexanodionacarboxilico y/o sus sales en combinacion con por lo menos un ester de acido acilciclohexanodionacarboxilico y su uso para mejorar el desarrollo de gramineas. |